Dr Jorg Taubel attending ACCP in San Diego

Posted:
5
September 2017

Dr Jorg Taubel will be attending the ACCP in San Diego, September 17-19, where he will be discussing his latest poster publications ‘The 24 Hour Profile of Moxifloxacin Effect on QTc – A Reflection of Diurnal Variations'

Back to news
More about usAdaptive Phase I, II & IIIBridging StudiesTQT StudiesPatient Recruitment

Meet the experts

Richmond Pharmacology has a team of experts with extensive knowledge of clinical research trials.

Latest Publications

View our latest peer-reviewed publications from a selection of our clinical trials.

Latest Videos

Learn more about Richmond Pharmacology by viewing some of our videos.

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Making gains in drug development

September 2, 2021
Keith Berelowitz outlines the innovations in the design and delivery of clinical trials
Read more

Inclisirin hailed as a 'gamechanger' gains approval for NHS patients

September 2, 2021
This novel therapeutic drug has potential to impact millions at risk of heart attack and stroke.
Read more

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more
© 2021 Richmond Pharmacology
EventsDisclaimerWebsitesSitemapPrivacy
Website by WOD.agency